ACG Wealth’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
ACG Wealth's EW Position: Q3 2022 in Review
ACG Wealth sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 682 shares — an estimated $65K sold.
ACG Wealth first reported a position in EW in Q2 2016 and held it in 23 quarters. The position peaked at $809K in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- ACG Wealth reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
- ACG Wealth sold 682 Edwards Lifesciences shares in Q3 2022, an estimated $65K.
- ACG Wealth first reported a position in Edwards Lifesciences in Q2 2016 and held it in 23 quarters.
- ACG Wealth's Edwards Lifesciences position peaked at $809K in Q4 2021.
- 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.